AWA
KURA icon

Aaron Wealth Advisors’s Kura Oncology KURA Stock Holding History

Aaron Wealth Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$740K Buy
67,455
+615
+0.9% +$5.8K 0.04% 323
2026
Q1 		$543K Sell
66,840
-302
-0.4% -$2.59K 0.03% 373
2025
Q4 		$698K Sell
67,142
-4
-0% -$42 0.04% 343
2025
Q3 		$594K Buy
67,146
+3,340
+5% +$23.8K 0.04% 362
2025
Q2 		$368K Sell
63,806
-1,980
-3% -$12.1K 0.04% 313
2025
Q1 		$434K Buy
65,786
+101
+0.2% +$787 0.05% 249
2024
Q4 		$572K Sell
65,685
-2,306
-3% -$33.2K 0.07% 182
2024
Q3 		$1.33M Sell
67,991
-2,157
-3% -$43.7K 0.16% 88
2024
Q2 		$1.44M Buy
70,148
+1,673
+2% +$34.4K 0.2% 67
2024
Q1 		$1.46M Buy
68,475
+13,529
+25% +$263K 0.21% 70
2023
Q4 		$790K Buy
54,946
+2,750
+5% +$27K 0.13% 99
2023
Q3 		$476K Sell
52,196
-4,439
-8% -$45.1K 0.06% 153
2023
Q2 		$599K Sell
56,635
-14
-0% -$166 0.08% 140
2023
Q1 		$693K Buy
56,649
+14
+0% +$175 0.1% 125
2022
Q4 		$703K Hold
56,635
– – 0.1% 116
2022
Q3 		$774K Sell
56,635
-89
-0.2% -$1.37K 0.14% 88
2022
Q2 		$1.04M Buy
56,724
+89
+0.2% +$1.28K 0.26% 60
2022
Q1 		$911K Sell
56,635
-178
-0.3% -$2.57K 0.21% 66
2021
Q4 		$795K Buy
56,813
+178
+0.3% +$2.88K 0.22% 63
2021
Q3 		$1.06M Sell
56,635
-21
-0% -$396 0.3% 46
2021
Q2 		$1.18M Buy
56,656
+4,864
+9% +$121K 0.39% 42
2021
Q1 		$1.46M Sell
51,792
-4,077
-7% -$129K 0.54% 34
2020
Q4 		$1.82M Buy
+55,869
New +$1.96M 0.67% 34

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Aaron Wealth Advisors's KURA Position: Q2 2026 in Review

Aaron Wealth Advisors increased its Kura Oncology (KURA) stake by 0.92% in Q2 2026, buying an estimated $5.8K and bringing the position to 67,455 shares worth $740K. The position accounts for 0.04% of the portfolio, ranked #323.

Aaron Wealth Advisors first reported a position in KURA in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.82M in Q4 2020. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Aaron Wealth Advisors held 67,455 shares of Kura Oncology worth $740K as of Q2 2026.
  • Aaron Wealth Advisors bought 615 Kura Oncology shares in Q2 2026, an estimated $5.8K.
  • Kura Oncology made up 0.04% of Aaron Wealth Advisors's portfolio in Q2 2026, its #323 holding.
  • Aaron Wealth Advisors first reported a position in Kura Oncology in Q4 2020 and has held it in 23 quarters since.
  • Aaron Wealth Advisors's Kura Oncology position peaked at $1.82M in Q4 2020.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Aaron Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.